3/A//SEC Filing
COLUMN GROUP III, LP 3/A
Accession 0001209191-20-010888
CIK 0001426332other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 9:49 PM ET
Size
17.3 KB
Accession
0001209191-20-010888
Insider Transaction Report
Form 3/AAmended
COLUMN GROUP III GP, LP
10% OwnerOther
Holdings
- 53,172
Common Stock
COLUMN GROUP III, LP
10% Owner
Holdings
- 53,172
Common Stock
COLUMN GROUP III-A, LP
10% Owner
Holdings
- 53,172
Common Stock
Footnotes (3)
- [F1]Consists of 24,972 shares of Common Stock held directly by The Column Group III, LP ("TCG III LP") and 28,200 shares of Common Stock held directly by The Column Group III-A, LP ("TCG III-A LP").
- [F2]The securities are directly held by TCG III LP, and indirectly held by The Column Group III GP, LP ("TCG III GP"), the general partner of TCG III LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
- [F3]The securities are directly held by TCG III-A LP, and indirectly held by TCG III GP, the general partner of TCG III-A LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001668159
Filing Metadata
- Form type
- 3/A
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 9:49 PM ET
- Size
- 17.3 KB